---
title: "Enliven Therapeutics (ELVN.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/ELVN.US/norm.md"
symbol: "ELVN.US"
name: "Enliven Therapeutics"
parent: "https://longbridge.com/zh-CN/quote/ELVN.US.md"
datetime: "2026-03-15T19:20:32.287Z"
locales:
  - [en](https://longbridge.com/en/quote/ELVN.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ELVN.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ELVN.US/norm.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/ELVN.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/ELVN.US/norm.md)


# Enliven Therapeutics (ELVN.US) — 财务报表

## 利润表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.4769 | -0.3245 | -0.4862 | -0.5703 | -0.4649 |
| ROE | -25.36% | -16.71% | -26.09% | -38.18% | -31.00% |
| Revenue | - | - | - | - | - |
| Net income | -29.67M | -20.15M | -25.34M | -28.54M | -23.18M |
| Operating income | -34.28M | -25.10M | -28.58M | -31.69M | -26.90M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 476.17M | 490.88M | 503.89M | 302.57M | 325.76M |
| Leverage | 1.04 | 1.03 | 1.03 | 1.05 | 1.05 |
| BVPS | 7.73 | 8.03 | 8.25 | 5.88 | 6.33 |
| Turnover | - | - | - | - | - |
| Cash & STI | 462.62M | 477.56M | 490.50M | 289.56M | 313.44M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 417000.00 | 874000.00 | 1.03M | 1.05M | 458000.00 |
| Net debt | -462.22M | -477.07M | -489.92M | -288.89M | -313.44M |

## 现金流量表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -15.84M | -13.28M | -17.06M | -24.13M | -17.20M |
| Investing CF | 12.38M | -4.06M | -183.59M | 1.43M | 727000.00 |
| Financing CF | 623000.00 | -368000.00 | 218.38M | 234000.00 | 39.97M |
| Free CF | -14.30M | -9.01M | -9.33M | -15.34M | -11.94M |
| OCF coverage | - | 1327900.00% | -12271.22% | -120635.00% | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | 0.0000 | 1000.00 | -139000.00 | -20000.00 | 0.0000 |